DXCM LEGAL NOTICE: Lose Money on Your DexCom, Inc. Investment? Contact BFA Law about the Securities Fraud Class Action Lawsuit before the Impending...
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ:DXCM) and certain of the Co...
DXCM INVESTOR ALERT: Edelson Lechtzin LLP Urges Dexcom, Inc. (NASDAQ: DXCM) Shareholders to Seek Legal Counsel About the Pending Securities Fraud C...
Edelson Lechtzin LLP is investigating securities fraud claims on behalf of investors of Dexcom Inc. common stock (NASDAQ: DXCM) between January 8, 2024, and July 25, 2024 NEWTOWN, PA / ACCESSWIRE /...
DXCM FRAUD UPDATE: A Class Action Lawsuit has been Filed Against DexCom, Inc. for Securities Fraud; Contact BFA Law Before Approaching October 21 C...
NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Com...
Levi & Korsinsky Reminds DexCom, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo...
DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights – DXCM
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DexCom, Inc. (DXCM)
LOS ANGELES, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 21, 2024 deadline to file a lead plaintiff motion in the class action fi...
DexCom Stock May Gain on Expanded Reach After Stelo's US Launch
DXCM announces that its OTC CGM, Stelo, is now available for purchase in the United States without a prescription.
Levi & Korsinsky Reminds DexCom, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM
NEW YORK , Aug. 27, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit. CLASS DEFINITION: ...
DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October ...
NEW YORK, NY / ACCESSWIRE / August 26, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM
NEW YORK , Aug. 26, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM). Such investors are advis...
Class Action Announcement (DXCM): A Securities Fraud Class Action Lawsuit Was Filed Against Dexcom, Inc.
RADNOR, PA / ACCESSWIRE / August 26, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United S...
Dexcom launches first over-the-counter continuous glucose monitor. Here's what it's like
Dexcom launched its first over-the-counter continuous glucose monitor called Stelo on Monday. Users can buy a one-month supply online for $99, or sign up for an ongoing subscription at $89 a month.
DXCM INVESTOR ALERT: DexCom, Inc. has been Sued for Securities Fraud – Investors that Suffered Losses are Urged to Contact BFA Law before October 2...
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Com...
Dexcom announces launch of over-the-counter continuous glucose monitor
Dexcom said on Monday its over-the-counter continuous glucose monitor Stelo is now available for use in the United States.
The Gross Law Firm Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - DXCM
NEW YORK , Aug. 26, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM). Shareholders who purchased shares of DXCM during the class pe...
Related Companies